Logo image of TELO

TELOMIR PHARMACEUTICALS INC (TELO) Stock Analyst Earnings Estimates

NASDAQ:TELO - Nasdaq - US87975F1049 - Common Stock

5.15  +0.22 (+4.46%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
TELO revenue by date.TELO revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
TELO ebitda by date.TELO ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TELO ebit by date.TELO ebit by date.
-138.1K-854.1K
-518.46%		-3.942M
-361.54%		N/AN/AN/A
-18.94%
Operating Margin
TELO operating margin by date.TELO operating margin by date.
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
TELO eps by date.TELO eps by date.
N/AN/AN/AN/AN/A
57.41%		N/A
21.74%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
TELO Yearly EPS VS EstimatesTELO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
TELO Yearly Revenue VS EstimatesTELO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 500K 1M 1.5M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% N/A
RevenueN/A N/A N/A N/A